title: Molecular imaging in oncology: the acceptance of PET/CT and the emergence of MR/PET imaging.
abstract: In the last decade, PET-only systems have been phased out and replaced with PET-CT systems. This merger of a functional and anatomical imaging modality turned out to be extremely useful in clinical practice. Currently, PET-CT is a major diagnostic tool in oncology. At the dawn of the merger of MRI and PET, another breakthrough in clinical imaging is expected. The combination of these imaging modalities is challenging, but has particular features such as imaging biological processes at the same time in specific body locations.
authors.forename: Christiaan
authors.initials: C
authors.lastname: Schiepers
authors.forename: Magnus
authors.initials: M
authors.lastname: Dahlbom
mesh_terms: D006801:Humans; D008279:Magnetic Resonance Imaging / Q000639:trends*; D008495:Medical Oncology / Q000639:trends*; D057054:Molecular Imaging / Q000639:trends*; D009369:Neoplasms / Q000175:diagnosis*; D049268:Positron-Emission Tomography / Q000639:trends*; D010818:Practice Patterns, Physicians' / Q000639:trends; D013382:Subtraction Technique / Q000639:trends*; D014057:Tomography, X-Ray Computed / Q000639:trends*